Breaking News Instant updates and real-time market news.

MA

MasterCard

$214.19

4.6 (2.19%)

, CMCSA

Comcast

$33.44

0.08 (0.24%)

20:25
07/25/18
07/25
20:25
07/25/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Mastercard (MA), consensus $1.53... Comcast (CMCSA), consensus 60c... McDonald's (MCD), consensus $1.92... Altria (MO), consensus $1... Bristol-Myers Squibb (BMY), consensus 87c... ConocoPhillips (COP), consensus $1.08... Celgene (CELG), consensus $2.11... Allergan (AGN), consensus $4.13... Raytheon (RTN), consensus $2.35... Praxair (PX), consensus $1.69... Valero Energy (VLO), consensus $1.99... Baxter International (BAX), consensus 71c... Marathon Petroleum (MPC), consensus $2.03... Spotify (SPOT), consensus (68c)... McKesson (MCK), consensus $2.88... KKR (KKR), consensus 45c... International Paper (IP), consensus $1.09... Hershey (HSY), consensus $1.10... American Airlines (AAL), consensus $1.59... L3 Technologies (LLL), consensus $2.32... D.R. Horton (DHI), consensus $1.08... Lear (LEA), consensus $4.99... Ally Financial (ALLY), consensus 71c... Invesco (IVZ), consensus 66c... Nielsen (NLSN), consensus 37c... Tractor Supply (TSCO), consensus $1.61... BorgWarner (BWA), consensus $1.10... Under Armour (UAA), consensus (8c)... Alaska Air (ALK), consensus $1.63... Helmerich & Payne (HP), consensus 4c... Xerox (XRX), consensus 83c... Dunkin' Brands (DNKN), consensus 74c... WWE (WWE), consensus 16c... Syntel (SYNT), consensus 44c... Tempur Sealy (TPX), consensus 63c.

MA

MasterCard

$214.19

4.6 (2.19%)

CMCSA

Comcast

$33.44

0.08 (0.24%)

CMCSK

Comcast

$0.00

(0.00%)

MCD

McDonald's

$158.86

0.93 (0.59%)

MO

Altria Group

$57.87

-0.12 (-0.21%)

BMY

Bristol-Myers

$59.05

0.785 (1.35%)

COP

ConocoPhillips

$71.49

0.65 (0.92%)

CELG

Celgene

$87.63

0.48 (0.55%)

AGN

Allergan

$176.76

1.84 (1.05%)

RTN

Raytheon

$197.45

0.48 (0.24%)

PX

Bought by LIN

$165.41

2.1 (1.29%)

VLO

Valero

$109.33

2.08 (1.94%)

BAX

Baxter

$76.50

0.99 (1.31%)

MPC

Marathon Petroleum

$74.70

0.97 (1.32%)

SPOT

Spotify

$187.84

-0.02 (-0.01%)

MCK

McKesson

$133.50

1.58 (1.20%)

KKR

KKR

$27.75

0.25 (0.91%)

IP

International Paper

$53.06

0.02 (0.04%)

HSY

Hershey

$92.85

0.79 (0.86%)

AAL

American Airlines

$38.15

0.76 (2.03%)

LLL

L3 Technologies

$200.33

-0.14 (-0.07%)

DHI

D.R. Horton

$39.54

-0.83 (-2.06%)

LEA

Lear

$181.53

2.175 (1.21%)

ALLY

Ally Financial

$27.97

0.1 (0.36%)

IVZ

Invesco

$26.36

0.125 (0.48%)

NLSN

Nielsen

$29.56

0.05 (0.17%)

TSCO

Tractor Supply

$78.15

-0.2 (-0.26%)

BWA

BorgWarner

$44.02

-0.41 (-0.92%)

UAA

Under Armour

$21.09

0.48 (2.33%)

UA

Under Armour

$19.73

0.49 (2.55%)

ALK

Alaska Air

$59.12

0.15 (0.25%)

HP

Helmerich & Payne

$58.78

-0.4 (-0.68%)

XRX

Xerox

$24.77

-0.02 (-0.08%)

DNKN

Dunkin' Brands

$70.92

-0.23 (-0.32%)

WWE

WWE

$81.27

0.29 (0.36%)

SYNT

Syntel

$40.69

-0.06 (-0.15%)

TPX

Tempur Sealy

$49.94

-1.15 (-2.25%)

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 13

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 06

    Sep

  • 12

    Sep

  • 18

    Sep

  • 28

    Oct

  • 29

    Oct

MA MasterCard
$214.19

4.6 (2.19%)

07/24/18
07/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kindred Biosciences (KIN) initiated with an Overweight at Cantor Fitzgerald. 2. HCP (HCP) initiated with an Equalweight at Capital One. 3. Domo (DOMO) initiated with an Outperform at Credit Suisse, Cowen, JMP Securities, and William Blair, an Overweight at Morgan Stanley, and a Neutral at UBS. 4. MasterCard (MA) initiated with an Outperform at Raymond James. 5. Alteryx (AYX) initiated with a Neutral at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
MSCO
07/19/18
NO CHANGE
MSCO
Morgan Stanley upgrades Payments and Processing industry to Attractive
Morgan Stanley analyst James Faucette upgraded his view of the Payments and Processing industry to Attractive, citing the firm's U.S. Strategy Team's call for rotation out of Technology and his view that Payments will be seen as an attractive option for investors looking to become more defensive. Investors underappreciate the resilience of consumer spending and Faucette sees the potential for his Payments coverage market-cap weighted earnings growth to accelerate organically to 15% over 2018-2020 from 11% growth over the last three years, he tells investors. In the group, the firm has Overweight ratings on Visa (V), MasterCard (MA), PayPal (PYPL), GreenSky (GSKY), Worldpay (WP) and FleetCor (FLT). Morgan Stanley has Underweight ratings on Western Union (WU) and On Deck Capital (ONDK), having downgraded On Deck this morning.
07/17/18
WOLF
07/17/18
INITIATION
Target $250
WOLF
Outperform
MasterCard initiated with an Outperform at Wolfe Research
Wolfe Research analyst Darrin Peller initiated MasterCard with an Outperform and $250 price target.
07/24/18
RAJA
07/24/18
INITIATION
Target $244
RAJA
Outperform
MasterCard initiated with an Outperform at Raymond James
Raymond James resumed coverage on MasterCard with an Outperform and $244 price target.
CMCSA Comcast
$33.44

0.08 (0.24%)

07/19/18
RAJA
07/19/18
UPGRADE
RAJA
Outperform
Comcast upgraded to Outperform from Market Perform at Raymond James
07/20/18
UBSW
07/20/18
DOWNGRADE
Target $50
UBSW
Neutral
21st Century Fox downgraded to Neutral from Buy at UBS
UBS analyst John Hodulik downgraded 21st Century Fox (FOXA) after Comcast (CMCSA) conceded to Disney (DIS) regarding an acquisition. Hodulik raised his price target to $50 from $48 on 21st Century Fox shares.
07/25/18
JPMS
07/25/18
NO CHANGE
JPMS
Overweight
Invalidated patent 'not material' to TiVo court fight, says JPMorgan
JPMorgan analyst Sterling Auty noted that the USPTO's Patent Trial and Appeal Board has declared patent 8,433,696 held by TiVo (TIVO) to be invalid as it believes that the technology involves a variation of earlier know-how. While a "scary headline," the reality is this does not matter in terms of TiVo's court case with Comcast (CMCSA), since this patent was dropped from the case, said Auty, who keeps an Overweight rating on TiVo shares.
07/20/18
JEFF
07/20/18
NO CHANGE
Target $41
JEFF
Buy
Comcast added to Franchise Pick List with $41 target at Jefferies
Jefferies analyst John Janedis added Comcast (CMCSA) to his firm's Franchise Pick List while keeping a Buy rating on the shares with a $41 price target. The analyst expects the "M&A driven volatility" to subside following Comcast's announcement to walk away from 21st Century Fox (FOXA). The stock remains attractively valued with the company's fundamentals "stable to improving," Janedis tells investors in a research note. He believes the outcome of Sky (SKYAY) "will not be a thesis changer" and that Comcast should see multiple expansion.
CMCSK Comcast
$0.00

(0.00%)

06/26/18
BUCK
06/26/18
INITIATION
BUCK
Neutral
Sky initiated with a Neutral at Buckingham
Earlier today, Buckingham analyst Michael Harrigan initiated Sky (SKYAY) with a Neutral rating and GBP14.50 price target with 3% upside, above Comcast's (CMCSA) GBP12.50 cash bid and a premium to 21st Century Fox's (FOXA) GBP10.75 bid to buy the 61% of Sky it does not already own. The analyst tells investors in a research note that a higher bid assessment could be triggered by the U.K. Takeover Panel exercising its authority to mandate a higher takeout bid if the price paid by Comcast or Disney (DIS) to buy the 21st Century Fox assets that are in play implies a higher bid.
07/13/18
07/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VF CORP DOUBLE UPGRADE: BofA Merrill Lynch analyst Robert Ohmes upgraded VF Corp (VFC) to Buy from Underperform and raised his price objective to $96 from $65 ahead of the company's earnings report on July 20, telling investors in a research note that he believes Vans will be a "go-to-brand" for the back-to-school selling season. He said his channel checks indicate accelerating momentum in Vans, especially classic styles, and that the $50-$60 price point is attractive given consumers' shift to value. RAYMOND JAMES DOWNGRADES AT&T: Raymond James downgraded AT&T (T) to Market Perform from Outperform. Analyst Frank Louthan said he views the Department of Justice appeal of the Time Warner case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail. AT&T is lower by 2% in late morning trading. STIFEL STARTS GALMED WITH A BUY: Stifel analyst Adam Walsh initiated Galmed (GLMD) with a Buy rating and $35 price target, calling it a "legitimate late-stage NASH play" after Aramchol recently proved itself in a Phase 2 trial as a clearly active and "very safe" compound for treating NASH. Galmed is trading higher by over 17% in late morning trading. MORGAN STANLEY HIKES WWE TARGET TO $100: Morgan Stanley analyst Benjamin Swinburne said that WWE (WWE), by securing rights fees in its new five-year agreements with NBC (CMCSA, CMCSK) and Fox (FOX, FOXA) that are 3.6 times higher than its prior five-year broadcast agreement with NBC, has gained a "massive increase" in earnings power and "extremely high" visibility into the associated revenue. Given the recently announced deals, he raised his price target on WWE shares to $100 from $58 and kept an Overweight rating on the stock. WILLIAM BLAIR CALLS KEMPER PULLBACK 'BUYING OPPORTUNITY': William Blair analyst Adam Klauber said he views shares of Kemper (KMPR) as "even more attractive" after the recent pullback, which he attributes to selling pressures from Infinity Property shareholders receiving Kemper stock. Klauber said Kemper "continues to be our top conviction idea," and kept an Outpeform rating on the name. Kemper is higher by 4.8% in late morning trading.
07/13/18
BERN
07/13/18
NO CHANGE
BERN
Bernstein 'not so sure' Comcast will give up on Fox assets
Bernstein analyst Todd Juenger said that it appears that the market is starting to believe Comcast (CMCSA) will give up on its bid to buy assets from 21st Century Fox (FOXA) and focus on Sky (SKYAY), but he said he is "not so sure" that is the case after only one counter from Disney (DIS). He does not believe Comcast would put forth a $35 bid unless it was prepared to bid up to near $45 per share, Juenger tells investors. If Comcast ups its bid, it either wins Fox at a high price or Disney is forced to pay more, which both seem better than giving up to him, Juenger stated. In any case, the "winner" will be left with increased leverage on a cyclical business late in the cycle at a time when it needs to invest significantly to build its direct-to-consumer business, added Juenger.
MCD McDonald's
$158.86

0.93 (0.59%)

07/11/18
CLVD
07/11/18
DOWNGRADE
CLVD
Neutral
McDonald's downgraded to Neutral from Buy at Cleveland Research
07/11/18
07/11/18
DOWNGRADE

Neutral
Cleveland Research downgrades McDonald's as checks lower confidence in upside
As previously reported, Cleveland Research analyst Steven Gojak downgraded McDonald's to Neutral from Buy after his industry checks led him to believe that its comparable sale results in the second half will trend more in-line with consensus expectations. Gojak, who is still modeling Q2 U.S. comp sales growth of 3.7% for McDonald's, which is above the 3.1% consensus growth view, lowered his 2018 U.S. comp estimate to 3.2% from 3.4%, compared to the consensus of 3.1% growth. He also cut his 2019 comp estimate to up 3%, down from up 3.5% and only slightly above the 2.9% consensus growth estimate.
07/11/18
07/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MCDONALD'S CUT TO NEUTRAL: Cleveland Research analyst Steven Gojak downgraded McDonald's (MCD) to Neutral from Buy after his industry checks led him to believe that its comparable sale results in the second half will trend more in-line with consensus expectations. Gojak, who is still modeling Q2 U.S. comp sales growth of 3.7% for McDonald's, which is above the 3.1% consensus growth view, lowered his 2018 U.S. comp estimate to 3.2% from 3.4%, compared to the consensus of 3.1% growth. McDonald's is down 1% in midday trading. NOMURA INITIATES INTERNET SECTOR: Nomura Instinet initiated coverage on the Americas Internet sector. Nomura Instinet initiated Alphabet Class A (GOOGL), Facebook (FB), and Spotify (SPOT) with Buy ratings, and added that Alphabet and Facebook were the best positioned in this newly regulated industry. It initiated Twitter (TWTR) with a Reduce rating, saying that while it is a "stable long-term asset that has something for everyone," the firm believes the market is pricing in "a significant advertising reacceleration that implies a shift in ad spend," while the firm expects "stability instead of a reacceleration of growth." CREDIT SUISSE POSITIVE ON VERIZON, NEGATIVE ON AT&T: Credit Suisse analyst Douglas Mitchelson initiated Verizon (VZ) with an Outperform rating and a price target of $58. The analyst believes Verizon should benefit from its "major $10B cost savings plan, stable capex spending, record low churn, and the benefit of tax reform." Mitchelson also initiated AT&T (T) with an Underperform rating and a price target of $29. Mitchelson said that AT&T will require greater scale and a shift to global direct-to-consumer distribution, stating that the elevated execution risk under its ownership structure and its wireless business look mature with little chance for stabilization in spite of the coming 5G technology. DISNEY VALUATION NOT COMPELLING: Credit Suisse analyst Douglas Mitchelson initiated Disney (DIS) with a Neutral rating and a price target of $114. The analyst noted that the company is "the best positioned traditional media company", but believes the Street has not sufficiently discounted the costs associated with Disney's push into direct-to-consumer streaming services, adding that FY19 will be extra challenging because of high film comps and major theme park project launches.
07/24/18
RBCM
07/24/18
NO CHANGE
Target $175
RBCM
Outperform
McDonald's Q2 to show continued international growth, says RBC Capital
RBC Capital analyst David Palmer kept his Outperform rating and $175 price target on McDonald's ahead of its Q2 results, saying the quarter should show ongoing "international lead growth" while the U.S. business continues to outperform the domestic fast food industry. The analyst adds that investors are undervaluing the company's corporate and U.S. system changes that will generate "more rapid share gains in 2019 and beyond".
MO Altria Group
$57.87

-0.12 (-0.21%)

07/23/18
PIPR
07/23/18
NO CHANGE
Target $75
PIPR
Overweight
Altria can still post 17% earnings growth in 2018, says Piper Jaffray
Piper Jaffray analyst Michael Lavery says that despite a new competitive challenge from JUUL, Altria Group can deliver double-digit earnings growth over the next three years and 17% growth in 2018 driven by pricing, tax savings and managing spending. This growth is attractive, especially with its 7% dividend yield, Lavery tells investors in a research note. The analyst keeps an Overweight rating on Altria Group with a $75 price target.
07/10/18
SBSH
07/10/18
NO CHANGE
SBSH
Juul having 'profound impact' on U.S. cigarette market, says Citi
Citi analyst Adam Spielman sees "good evidence" that Juul is impacting cigarette volumes in the U.S. and will continue to do so. The analyst is also concerned that a ban on menthol cigarettes is now more likely. Further, Juul's international expansion is "yet another factor making tobacco less predictable," Spielman tells investors in a research note. The analyst believes the share declines in Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM) "have been more or less fair."
06/01/18
JEFF
06/01/18
NO CHANGE
Target $70
JEFF
Buy
Jefferies lowers Altria target to $70, remains bullish on shares
Jefferies analyst Owen Bennett lowered his price target for Altria Group to $70 from $84 to reflect market concerns about the new tobacco model. These are misplaced, but are unlikely to go away in the next 12-18 months, Bennett tells investors in a research note. The analyst sees a "near-term re-rating opportunity" and remains bullish on Altria over the next 12 months. He keeps a Buy rating on the stock.
04/30/18
04/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Outperform from Sector Perform at RBC Capital with analyst Nik Modi saying while his concerns around the macro backdrop and fundamentals persist, the current valuation of 13-times forward PE is attractive relative to the broader Consumer Packaged Goods category given the company's potential catalysts of more dividend increases tracking higher interest rates and the FDA approval process for IQOS electronic cigarettes. 2. Aaron's (AAN) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying he remains "impressed" by Progressive's revenue growth and thinks the unit will benefit from Rent-A-Center's (RCII) "ongoing struggles." 3. Cirrus Logic (CRUS) upgraded to Buy from Hold at Craig-Hallum with analyst Anthony Stoss saying he believes Apple (AAPL) headwinds are already priced into the stock and a relief rally is likely following the company's upcoming earnings this Wednesday. 4. Ventas (VTR) upgraded to Market Perform from Underperform at BMO Capital with John Kim citing a more attractive valuation after the stock price came down another 19% in 2018. 5. New York Times (NYT) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani saying she believes digital demand will likely drive further "outsized growth" for New York Times. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BMY Bristol-Myers
$59.05

0.785 (1.35%)

06/19/18
06/19/18
DOWNGRADE
Target $300

In Line
Madrigal cut to In Line at Evercore ISI following run-up in price, expectations
As previously reported, Evercore ISI analyst Josh Schimmer downgraded Madrigal Pharmaceuticals (MDGL) to In Line from Outperform, stating that he has no real incremental reason to raise his $300 price target, which the stock has achieved following the company's encouraging Phase 2 results for MGL-3196 and a Bloomberg report that has driven takeover speculation. Given current investor sentiment, anything short of either an acquisition or a "massive" collaboration like Bristol-Myers' (BMY) with Nektar (NKTR) will fall short of expectations, Schimmer tells investors.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/23/18
BMOC
07/23/18
NO CHANGE
Target $51
BMOC
Market Perform
Bristol-Myers price target raised to $51 from $47 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Bristol-Myers to $51, saying the company's Opdivo+Yervoil will likely top consensus thanks to "good growth" in the U.S. markets and that the Eliquis RX trends were likely "remarkably strong". The analyst further states that the stock price should respond positively to the likely earnings beat and may lead to some "takeout speculation", particularly if the sustainability of its immuno-oncology franchse is made clearer. Arfaei also keeps his Market Perform rating, adding that at current price levels, risk-reward is not favorable for the stock.
06/28/18
WELS
06/28/18
NO CHANGE
WELS
Wells says Amazon deal, Walgreens results have negative read for drug pricing
After Amazon (AMZN) agreed to acquire online pharmacy PillPack, reportedly for $1B, Wells Fargo analyst David Maris noted that he has long stated that Amazon would enter the pharmacy business and warned about the risk to drug pricing in such a scenario. Maris also noted that Walgreens (WBA) reported its U.S. retail pharmacy comparable store sales fell 1.2% in Q3, adding that retailers tend to push drugmakers on price when they feel pressure and the read-through from its report may be negative for drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
COP ConocoPhillips
$71.49

0.65 (0.92%)

07/11/18
LEHM
07/11/18
DOWNGRADE
Target $66
LEHM
Underweight
Barclays downgrades Hess to Underweight on 'steepest' group premium
Barclays analyst Paul Cheng downgraded Hess Corp. (HES) to Underweight from Equal Weight while raising his price target for the shares to $66 from $55. The analyst says his analysis indicates Hess trades at the "steepest premium" in the group. His Guyana estimate would need to move 75%-100% higher for Hess to trade in-line with large-cap Exploration and Production companies. Cheng replaced Cenovus Energy (CVE) with ConocoPhillips (COP) as his top pick following the stock's strong share performance. He also double upgraded Petrobras (PBR) Overweight from Underweight, upgraded Husky Energy (HUSKF) to Overweight and Imperial Oil (IMO) to Equal Weight. The analyst thinks Hess and Exxon Mobil (XOM) offer the least value over the next 12 months.
07/12/18
MSCO
07/12/18
INITIATION
Target $82
MSCO
Overweight
ConocoPhillips initiated with an Overweight at Morgan Stanley
Morgan Stanley analysts Devin McDermott and Drew Venker added coverage of 12 large-cap and diversified E&Ps, identifying ConocoPhillips (COP), Occidental Petroleum (OXY) and Continental Resources (CLR) as their top picks. The analysts set an $82 price target on Overweight-rated ConocoPhillips.
07/24/18
MZHO
07/24/18
INITIATION
Target $173
MZHO
Buy
Mizuho names 'Apple of oil' EOG top pick in Oil & Gas sector
Mizuho analyst Paul Sankey last night initiated 10 names in the Global Oil & Gas group with five buys, four neutrals and one underperform. He also maintained a Buy rating on Occidental Petroleum (OXY) and Neutral rating on ConocoPhillips (COP). The analyst put Buy ratings on EOG Resources (EOG), his top pick in the group, Anadarko Petroleum (APC), Pioneer Natural Resources (PXD), Noble Energy (NBL) and Suncor (SU). Sankey calls EOG the Apple (AAPL) of oil. The company has been a pioneer in unconventional oil development in the U.S. and its technology-driven, innovation-focused approach will continue to drive peer-leading rates of return and oil growth, the analyst contends. He put Neutral ratings on Devon Energy (DVN), Hess Corp. (HES), Marathon Oil (MRO) and Apache (APA). Lastly, Sankey initiated Murphy Oil (MUR) with an Underperform rating and $36 price target. While the stock trades well below peers on both mid-cycle free cash and discount to net asset value, there is not enough potential upside to justify a Neutral at this point, Sankey told investors in a research note.
06/11/18
BMOC
06/11/18
INITIATION
Target $78
BMOC
Outperform
ConocoPhillips initiated with an Outperform at BMO Capital
BMO Capital analyst Phillip Jungwirth initiated ConocoPhillips with an Outperform rating and a price target of $78. The analyst expects the company's "Brent-levered, low-capital-intensive portfolio" to generate free cash flows that are 20%-30% above the management' payout target. Jungwirth also notes ConocoPhillips' "core shale position, conventional project start-up in the near term, and a stable LNG-oil sands production driving output growth". The analyst models $21B of excess free cash flows through FY22 or 26% of its current market cap after including the FY18 dividend payout and debt repayment.
CELG Celgene
$87.63

0.48 (0.55%)

07/24/18
JPMS
07/24/18
NO CHANGE
JPMS
Overweight
Celgene positive headline streak continues, says JPMorgan
Last night's positive topline data for Revlimid plus Rituxan in relapsed/refractory indolent lymphoma is a "clear win" at a time when Celgene "really needed a string of favorable events," JPMorgan analyst Cory Kasimov tells investors in a research note titled "Positive Headline Streak Continues with AUGMENT." The analyst sees this indication as a "meaningful" near-term sales opportunity for the franchise prior to loss of exclusivity, potentially $600M in the U.S. alone. He expects the positive data to "modestly bolster sentiment" into Celgene's Q2 results. Kasimov keeps an Overweight rating on the shares.
07/22/18
PIPR
07/22/18
NO CHANGE
Target $125
PIPR
Overweight
Agios' Tibsovo approved earlier, launch should go well, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren notes that Agios (AGIO) announced the FDA approval of Tibsovo for relapsed/refractory acute myeloid leukemia, which represents the company's second approved drug product within the past year. The analyst points out that both Tibsovo and Idhifa, which was approved August 2017, cover approximately 20% of all AML patients who harbor IDHm mutations. Due to partner Celgene (CELG) and Agios' existing Idhifa launch efforts and the strong awareness of and similarity between both products, Van Buren expects the Tibsovo launch to be as good as - if not better - than the early Idhifa launch. Over time, he believes that Tibsovo can treat the majority of U.S; AML patients with IDH1 mutations and generate sales approaching $150M. The analyst reiterates an Overweight rating and $125 price target on Agios shares.
07/12/18
PIPR
07/12/18
NO CHANGE
Target $95
PIPR
Neutral
PTAB decision on Gilenya positive for Celgene, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond expects the market to react positively with respect to Celgene (CELG) shares, at least initially, following the Patent Trial and Appeal Board decision regarding ozanimod competitor Gilenya from Novartis (NVS). Yesterday, the PTAB issued a decision that upholds validity of Gilenya's dosing patent in response to inter partes review petitions from multiple generic filers, Raymond tells investors in a research note. While this decision will likely be appealed, it opens up the possibility for Gilenya intellectual property runway out to 2027, when the dosing patent expire, the analyst adds. Raymond believes that not having a generic S1P class at launch for ozanimod is positive for Celgene. However, without the removal of first dose monitoring, ozanimod is not likely to be differentiated enough to make a difference, the analyst says, citing physician feedback. He keeps a Neutral rating on Celgene with a $95 price target. The stock in early trading is up 2% to $84.92.
07/11/18
ADAM
07/11/18
NO CHANGE
Target $140
ADAM
Buy
Celgene's Buy rating backed at Canaccord following Phase 3 Impassion130 results
Canaccord analyst John Newman maintained a Buy rating and $140 price target on Celgene (CELG) after the company said that the Phase 3 Impassion130 study showed progression-free survival, or PFS, improvement for 1L metastatic or unresectable triple negative breast cancer with Abraxane plus Tecentriq (RHHBY) , which opens the door to Tencentriq in this indication. In a research note to investors, Newman says he expects continued upside from pipeline advances and diversification based on in-licensing, M&A and organic R&D and that, as there are currently no alternatives to chemotherapy, the combination of Abraxane plus Tecentriq should see widespread use if approved. He views the advances in TNBC "very positively" given the high unmet need for viable therapy.
AGN Allergan
$176.76

1.84 (1.05%)

07/09/18
MZHO
07/09/18
NO CHANGE
Target $194
MZHO
Neutral
Allergan price target raised to $194 from $176 at Mizuho
Mizuho analyst Irina Koffler raised her price target for Allergan to $194 after extending her model to 2025 to "assess the beneficial impact" of the company's pipeline. Her new price target reflects a long-term outlook but the analyst reiterates a Neutral rating on Allergan.
07/19/18
PIPR
07/19/18
NO CHANGE
Target $450
PIPR
Overweight
Regeneron overhang 'effectively lifted' after Allergan data, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond noted that Allergan (AGN) and Molecular Partners disclosed data from two Phase 3 trials comparing the latest DARPin formulation to Lucentis in age-related macular degeneration, calling the data "decidedly a non-starter." While few Regeneron (REGN) investors have expressed concern to Raymond over looming DARPin data, any overhang that did exist due to worries about another potential Eylea competitor in the AMD space have "been effectively lifted" following the DARPin data, said the analyst. He remains a buyer of Regeneron shares and keeps an Overweight rating and $450 price target on the stock.
07/19/18
WELS
07/19/18
NO CHANGE
Target $240
WELS
Outperform
Allergan wet AMD data exceed 'unofficial benchmark,' says Wells Fargo
The released efficacy data from Allergan's (AGN) two Phase III trials of its anti-VEGF treatment abicipar in wet age-related macular degeneration looks to have exceeded the "unofficial benchmark set by potential extended-duration competitors," Novartis' (NVS) brolucizumab and Regeneron's (REGN) Eylea, Wells Fargo analyst David Maris tells investors in a research note. The analyst forecasts $125M in sales for abicipar in its first year on the market in 2020 and estimates it will grow to $500M in 2022. Maris keeps an Outperform rating on Allergan with a $240 price target.
07/12/18
CANT
07/12/18
INITIATION
Target $59
CANT
Overweight
Cantor puts $59 price target on 'undervalued' NASH play Galmed
Cantor Fitzgerald analyst Elemer Piros last night initiated coverage of Galmed Pharmaceuticals (GLMD) with an Overweight rating and $59 price target. The stock closed yesterday down 45c to $10.55. The company is developing Aramchol, a novel, once-daily, oral therapy to treat liver diseases using fattyacid/bile-acid conjugates, Piros tells investors in a research note. The analyst believes that by Q4 of 2019, only three meaningful non-alcoholic steatohepatitis pivotal programs will be in development: Allergan's (AGN) cenicriviroc, Madrigal Pharmaceuticals' (MDGL) MGL-3196, and Galmed's Aramchol. Of the three drugs, Galmed's has the highest likelihood of achieving improvement on NASH resolution without worsening of fibrosis, and improvement in fibrosis score without worsening of NASH, Piros argues. He believes Galmed is undervalued relative to peers in the NASH space.
RTN Raytheon
$197.45

0.48 (0.24%)

05/22/18
05/22/18
DOWNGRADE
Target $219

Neutral
Raytheon downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Robert Spingarn downgraded Raytheon to Neutral from Outperform saying that while it has a number of solid opportunities in front of it, including the new Long Range Stand-off Weapon and hypersonics, the current share price largely reflects this upside. The analyst also lowered his price target on the shares to $219 from $250.
05/09/18
BERN
05/09/18
NO CHANGE
BERN
U.S. exiting Iran deal minor negative for Boeing, Airbus, says Bernstein
Bernstein analyst Douglas Harned notes that President Trump announced that the U.S. will withdraw from the 2015 Iran nuclear accord, and will reinstate sanctions on that country. The analyst sees only minimal impact to commercial aerospace as neither Airbus (EADSY) nor Boeing (BA) will change production rates on this change, and the total number of orders affected represents just 2% of the companies' combined order backlogs. For defense contractors with significant Middle Eastern exposure, heightened regional tensions could drive increased demand for missile defense, in particular, but potentially also aircraft, ships, missiles, and vehicles, he contends. Harned believes Raytheon (RTN) is well positioned, having the highest exposure to missile defense and tactical missile sales to the Middle East, with Lockheed Martin (LMT) also a strong player.
05/24/18
STFL
05/24/18
NO CHANGE
Target $65
STFL
Buy
AeroVironment well-positioned to win new Army contract, says Stifel
Separate from AeroVironment's (AVAV) recent Switchblade contract announcement, Stifel analyst Joseph DeNardi highlighted that the Army recently posted a request for information for Switchblade production from FY19-FY26. DeNardi said it is unclear what the likelihood is that AeroVironment continues to be the sole-source Switchblade provider as it has been from FY17-FY19, as he assumes multiple contractors will reply and suspects that offerings presumably from companies like Raytheon (RTN), Textron (TXT) and possibly Lockheed (LMT) will be more mature than they were a few years ago. Still, he is encouraged by the length of the performance period for the new RFI and views AeroVironment as well-positioned to win the competition, DeNardi tells investors. He keeps a Buy rating and $65 price target on the stock.
05/22/18
FBCO
05/22/18
DOWNGRADE
FBCO
Neutral
Raytheon downgraded to Neutral from Outperform at Credit Suisse
PX Bought by LIN
$165.41

2.1 (1.29%)

05/30/18
JPMS
05/30/18
UPGRADE
JPMS
Overweight
Linde upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alberto Rueda upgraded Linde (LNEGY) to Overweight and raised his price target for the shares to EUR 217 from EUR 212. The analyst has increased confidence in "substantial" upside from the proposed merger with Praxair (PX).
03/19/18
SBSH
03/19/18
NO CHANGE
SBSH
Buy
Praxair shares could fall 10%-15% initially if deal fails, says Citi
Citi analyst P.J. Juvekar believes Praxair (PX) shares could initially fall 10%-15% if the merger with Linde were to fail due to regulatory restrictions. The analyst, however, thinks shares should eventually trade based on its standalone merits, which he remains positive on. He recommends playing the deal through Praxair over Linde. Juvekar keeps a Buy rating on the shares.
01/29/18
JPMS
01/29/18
DOWNGRADE
Target $170
JPMS
Neutral
Air Products downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Air Products and Chemicals (APD) to Neutral while raising his price target for the shares to $170 from $168. At current valuation levels, the analyst prefers shares of Praxair (PX) in the industrial gas sector.
03/27/18
BMOC
03/27/18
INITIATION
Target $159
BMOC
Market Perform
Praxair initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Praxair with a Market Perform rating and $159 price target.
VLO Valero
$109.33

2.08 (1.94%)

05/18/18
TUDR
05/18/18
UPGRADE
TUDR
Buy
Valero upgraded to Buy from Hold at Tudor Pickering
06/29/18
USCA
06/29/18
UPGRADE
USCA
Overeight
Valero upgraded to Overeight from Hold at US Capital Advisors
06/04/18
FBCO
06/04/18
NO CHANGE
Target $135
FBCO
Neutral
Valero price target raised to $135 from $118 at Credit Suisse
Credit Suisse analyst Manav Gupta raised his price target for Valero to $135 from $118 as he expects wider heavy light diffs, light -light diffs and lower RINs will work in the company's favor, offset effects of unplanned downtime at Texas City refinery. The analyst reiterates a Neutral rating on the shares.
05/29/18
WELS
05/29/18
NO CHANGE
Target $146
WELS
Outperform
Valero price target raised to $146 from $122 at Wells Fargo
Wells Fargo analyst Roger Read raised his price target for Valero to $146 from $122 saying the IMO 2020 low sulfur marine fuel rule in his estimation will be a positive for the U.S. Independent Refiners. The analyst reiterates an Outperform rating on the shares as he believes Valero possesses meaningful upside.
BAX Baxter
$76.50

0.99 (1.31%)

05/14/18
ARGS
05/14/18
NO CHANGE
ARGS
Hold
Baxter pullback would warrant a potential upgrade, says Argus
Argus analyst John Eade kept his Hold rating on Baxter after the company's Q1 earnings beat and raised FY18 outlook, saying he would consider an upgrade if the stock price pulled back to the mid-$60's range. The analyst notes that Baxter has "substantially improved profitability in recent quarters" even as it continues to rely on M&A as a source of revenue and margin growth. Eade adds that while the company's Renal and Hospital Products segments are mature businesses, the company's balance sheet is clean, and the management's recent dividend raise is indicative of its confidence in Baxter's prospects.
05/22/18
PIPR
05/22/18
NO CHANGE
Target $77
PIPR
Overweight
Baxter buybacks should push shares higher, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says the long-term guidance Baxter announced yesterday at its analyst meeting is essentially in-line with expectations. The key takeaways are the innovation Baxter is delivering, with $1.7B in new products expected over the next five years, and its "sizable" free cash flow, O'Brien tells investors in a research note. The cash flow will allow the company to execute accretive deals or share repurchases, conceivably as much as 20% of outstanding stock, the analyst adds. He believes this could push shares higher in the coming quarters and keeps an Overweight rating on Baxter with a $77 price target. O'Brien encourages investors to start or build positions in the name.
05/17/18
05/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Costco (COST) initiated with a Buy at Loop Capital. 2. Align Technology (ALGN) initiated with an Outperform at Evercore ISI. 3. Baxter (BAX) assumed with an Overweight at Piper Jaffray. 4. Comtech (CMTL) initiated with a Neutral at Citi. 5. Helius Medical (HSDT) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
PIPR
05/17/18
INITIATION
Target $77
PIPR
Overweight
Baxter assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien assumed coverage of Baxter International with an Overweight rating and $77 price target. Management has done an "excellent job" in quickly turning the company around, O'Brien tells investors in a research note. He believes there is further gross margin expansion available to push earnings higher and that the company's "clean" balance sheet should provide opportunity to do an accretive deal.
MPC Marathon Petroleum
$74.70

0.97 (1.32%)

05/29/18
05/29/18
UPGRADE
Target $113

Outperform
Marathon Petroleum upgraded to Outperform from at Wells Fargo
As previously reported, Wells Fargo analyst Roger Read upgraded Marathon Petroleum to Outperform from Market Perform and raised his price target on the shares to $113 from $80. The analyst says the IMO 2020 low sulfur marine fuel rule in his estimation will be a positive for the U.S. Independent Refiners and believes possesses the most potential upside.
05/18/18
FBCO
05/18/18
DOWNGRADE
Target $145
FBCO
Neutral
Andeavor downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Manav Gupta downgraded Andeavor (ANDV) to Neutral from Outperform and raised his price target on shares to $145 from $142. In a research note to investors, Gupta said he believes Marathon Petroleum's (MPC) bid fairly values Andeavor and does not expect a competing bid that limits upside vs. current share prices, adding that any delays on the regulatory front are likely to disproportionally impact Andeavor more than Marathon.
05/18/18
TUDR
05/18/18
DOWNGRADE
TUDR
Hold
Marathon Petroleum downgraded to Hold from Buy at Tudor Pickering
05/29/18
WELS
05/29/18
UPGRADE
WELS
Outperform
Marathon Petroleum upgraded to Outperform from Market Perform at Wells Fargo
SPOT Spotify
$187.84

-0.02 (-0.01%)

07/25/18
07/25/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VERTICAL GROUP RAISES SNAP RATING: Vertical Group analyst Phil Leggiere upgraded Snap (SNAP) to Mixed from Negative citing expectations for strong second half 2018 spending. Snap is higher by over 1% in late morning trading. PIVOTAL CUTS SPOTIFY TO HOLD: Pivotal Research analyst Jeffrey Wlodarczak downgraded Spotify (SPOT) to Hold from Buy with an unchanged price target of $200. The analyst cited valuation for the downgrade, given the "material rise" in the shares since his initiation report on May 29. Further, he increasingly views consensus 2018 premium monthly active user growth expectations as too aggressive. He lowered his Q2 premium subscriber MAU estimate from 6M to 5.5M, versus the consensus at 7M. Spotify's current valuation is fair and does not leave a lot of room for "operational/market hiccups," Wlodarczak told investors. DEUTSCHE SEES AMERITRADE/E-TRADE MERGER MAKING SENSE: Deutsche Bank analyst Brian Bedell continues to see a merger between TD Ameritrade (AMTD) and E-Trade (ETFC) as making strategic and financial sense. With TD Ameritrade's integration of recently acquired Scottrade progressing better than expectations, a merger scenario with E-Trade is "becoming more compelling," Bedell told investors. He updated his merger scenario model, raising his hypothetical merger scenario value of E-Trade from TD Ameritrade's perspective to $77 from $72, nearly a 30% premium to the current share price. Bedell raised his price target for TD Ameritrade to $77 from $72 and for E-Trade to $72 from $70. He kept Buy ratings on both stocks. GORDON HASKETT UPGRADES TARGET, DOWNGRADES WALMART: Gordon Haskett analyst Chuck Grom upgraded Target (TGT) to Accumulate from Hold and raised his price target on shares to $86 from 74 to reflect the recent acceleration in traffic. Grom said geolocation data and proprietary card data support his Q2 4.5% comp growth estimate. Grom also downgraded Walmart (WMT) to Hold from Accumulate and lowered its price target to $92 from $98. Grom thinks there are few near-term catalysts on the horizon and said the margin outlook is not as transparent following a period of improvement and stabilization. He expects Walmart shares to be range bound for the balance of the year.
07/25/18
07/25/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Spotify (SPOT) downgraded to Hold from Buy at Pivotal Research with analyst Jeffrey Wlodarczak citing valuation. 2. Eli Lilly (LLY) downgraded to Hold from Buy at Berenberg with analyst Laura Sutcliffe saying the company reported "very good" Q2 results and its sales growth is built on the "solid proposition" of Trulicity, but the company is in the process of re-stocking its late-stage pipeline both internally and via deals. 3. Walmart (WMT) downgraded to Hold from Accumulate at Gordon Haskett with analyst Chuck Grom saying he thinks there are few near-term catalysts on the horizon and the margin outlook is not as transparent following a period of improvement and stabilization, and expects shares to be range bound for the balance of the year. 4. Hormel Foods (HRL) downgraded to Underperform from Neutral at Mizuho with analyst Jeremy Scott saying "volatile and retreating" pork margins bring rising risks to Hormel's earnings. 5. BJ's Wholesale (BJ) downgraded to Accumulate from Buy at Gordon Haskett with analyst Chuck Grom citing share strength following the IPO. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/25/18
MSCO
07/25/18
NO CHANGE
Target $190
MSCO
Overweight
Apple Music threat to Spotify 'manageable,' says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne notes that streaming adoption is accelerating and he believes rising smartphone penetration, increased wireless network capacity, smart speaker adoption and connected cars can support a market with multiple "winners." Additionally, Android's global lead over iOS suggests the threat to Spotify (SPOT), the global leader in music streaming, from Apple Music (AAPL) is "manageable," Swinburne tells investors. He maintains an Overweight rating and $190 price target on Spotify shares, though he sees a "bull case" for the stock reaching $300 per share.
07/25/18
DBAB
07/25/18
NO CHANGE
Target $170
DBAB
Hold
Spotify price target raised to $170 from $155 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Spotify to $170 ahead of the company's Q2 results and keeps a Hold rating on the shares. The analyst expects "solid" near-term results from Spotify as the company benefits from some new country launches and enhancements to its free trial. He also sees the company's gross margins continuing to benefit from improvement in ad monetization and the benefit from the latest major label deals.
MCK McKesson
$133.50

1.58 (1.20%)

07/20/18
07/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Philip Morris (PM) downgraded to Neutral from Overweight at JPMorgan and to Market Perform from Outperform at Cowen. 2. Skechers (SKX) downgraded to Neutral from Positive at Susquehanna and to Market Perform from Outperform at Wells Fargo. 3. McKesson (MCK), AmerisourceBergen (ABC), and Express Scripts (ESRX) downgraded to Neutral from Outperform at Baird. 4. Five Below (FIVE) downgraded to Neutral from Outperform at Credit Suisse with analyst Judah Frommer saying he is moving to the sidelines as he sees risk/reward balanced at current levels given the stock's material outperformance and back-half comp acceleration that he believes is priced into shares. 5. Yum China (YUMC) downgraded to Underperform from Neutral at BofA/Merrill with analyst Chen Luo saying he expects Yum China to continue to underperform given a likely peak in KFC trends amid China's weakening macro environment, a likely prolonged turnaround at Pizza Hut combined with heavy costs, a slowdown in Chinese consumer consumption, and RMB depreciation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/18
BARD
07/20/18
DOWNGRADE
BARD
Neutral
Express Scripts, AmerisourceBergen, McKesson cut to Neutral at Baird
As previously reported, Baird analyst Eric Coldwell downgraded Express Scripts (ESRX), AmerisourceBergen (ABC) and McKesson (MCK), all to Neutral from Outperform, citing the heavy political attack in recent weeks against PBMs and members of the drug supply chain. Among them, he said AmerisourceBergen remains his preferred name, but he cannot justify putting new money to work in these names in the current environment, stating that visibility has deteriorated further across the supply chain.
07/20/18
BARD
07/20/18
DOWNGRADE
BARD
Neutral
McKesson downgraded to Neutral from Outperform at Baird
07/20/18
07/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS YUM CHINA TO UNDERPERFORM: BofA Merrill Lynch analyst Chen Luo downgraded Yum China (YUMC) to Underperform from Neutral and cut its price target to $34 from $44.30. Luo said he expects Yum China to continue to underperform given a likely peak in KFC trends amid China's weakening macro environment, a likely prolonged turnaround at Pizza Hut combined with heavy costs, a slowdown in Chinese consumer consumption, and RMB depreciation. Yum China is down 4.8% in late morning trading. CREDIT SUISSE CUTS FIVE BELOW TO NEUTRAL: Credit Suisse analyst Judah Frommer downgraded Five Below (FIVE) to Neutral from Outperform, telling investors that he is moving to the sidelines as he sees risk/reward balanced at current levels given the stock's material outperformance and back-half comp acceleration that he believes is priced into shares. Frommer keeps his $110 price target and says Five Below remains one of the most differentiated concepts in retail. Five Below is down 4.4% in late morning trading. BAIRD MORE CAUTIOUS ON DRUG SUPPLY CHAIN: Baird analyst Eric Coldwell downgraded Express Scripts (ESRX), AmerisourceBergen (ABC), and McKesson (MCK), all to Neutral from Outperform, citing the heavy political attack in recent weeks against pharmacy benefit managers and members of the drug supply chain. Among them, he said AmerisourceBergen remains his preferred name, but he cannot justify putting new money to work in these names in the current environment. SUNTRUST STARTS VIKING WITH A BUY: SunTrust analyst Edward Nash initiated Viking Therapeutics (VKTX) with a Buy rating and a price target of $14, saying its VK2809 drug for lipid disorders "has the potential to become a promising treatment by addressing multiple metabolic issues" associated with the non-alcoholic steatohepatitis disease, or NASH. Viking is up 8.3% in late morning trading. JPMORGAN SAYS BUY GM, SELL TESLA INTO EARNINGS: JPMorgan analyst Ryan Brinkman forecast lower than consensus Q2 earnings for Ford (F) and higher than consensus earnings for General Motors (GM). The analyst is also concerned about the potential for a "large loss and accompanying large cash outflow" at Tesla (TSLA) in Q2 to "make the bridge" to GAAP profitability and positive cash generation in the second half of the year. Brinkman maintained Overweight ratings on GM and Ford, with a preference for GM shares. He also kept his cautious Underweight rating on Tesla shares, seeing 44% downside to his $180 December 2018 price target.
KKR KKR
$27.75

0.25 (0.91%)

06/27/18
RHCO
06/27/18
NO CHANGE
Target $30
RHCO
Buy
Web.com price target raised to $30 from $24 at SunTrust
SunTrust analyst Naved Khan raised his price target on Web.com to $30, maintaining his view that the company's agreed acquisition by Siris Capital at $25 per share could generate interest from other potential buyers. Among the potential acquirers, the analyst lists Silver Lake, KKR (KKR), Vector Capital, and GoDaddy (GDDY).
07/10/18
WELS
07/10/18
NO CHANGE
Target $30
WELS
Outperform
KKR price target raised to $30 from $25 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for KKR to $30 from $25 after attending the company's Investor Day and as he believes the outlook appears to remain quite promising. The analyst reiterates an Outperform rating on the shares.
07/10/18
JMPS
07/10/18
NO CHANGE
Target $33
JMPS
Outperform
KKR price target raised to $33 at JMP Securities after 'impressive' analyst day
JMP Securities analyst Devin Ryan said KKR's investor day was "impressive" and made a compelling pitch for existing and new investors. The recurring themes were that growth opportunities abound, management views the business as at an "inflection" with even more excitement about the future, and the company is focused on simplifying its story and providing more transparency. Following the event, he increased his price target on KKR shares to $33 from $27 and maintains his Outperform rating on the stock.
07/10/18
SBSH
07/10/18
NO CHANGE
Target $31
SBSH
Buy
KKR price target raised to $31 from $28 at Citi
Citi analyst William Katz raised his price target for KKR to $31 and keeps a Buy rating on the shares following the company's investor day. The analyst believes KKR's conversion to a corporation has created a "favorable feedback loop for the sector."
IP International Paper
$53.06

0.02 (0.04%)

07/09/18
WELS
07/09/18
NO CHANGE
Target $70
WELS
Outperform
International Paper price target raised to $70 from $62 at Wells Fargo
Wells Fargo analyst Gabe Hajde raised his price target for International Paper to $70 from $62 and recommends buying the stock ahead of Q2 earnings. The analyst reiterates an Outperform rating on the shares.
07/23/18
07/23/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Buy at BTIG. 2. BJ's Wholesale (BJ) initiated with an Outperform at William Blair and Baird, a Buy at Jefferies, BofA/Merrill, Citi, and Nomura Instinet, an Equal Weight at Morgan Stanley, a Market Perform at Wells Fargo, as well as a Neutral at JPMorgan, and Goldman Sachs. 3. EverQuote (EVER) initiated with an Overweight at JPMorgan, an Outperform at JMP Securities, Oppenheimer, and William Blair, a Buy at Canaccord and BofA/Merrill, as well as a Market Perform at Raymond James. 4. International Paper (IP) resumed with a Buy at Citi. 5. Centene (CNC) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/18
SPHN
07/05/18
NO CHANGE
SPHN
Equal Weight
WestRock, International Paper price targets cut at Stephens
Stephens analyst Mark Connelly lowered his price target on WestRock (WRK) to $63 from $74 and cut his target for International Paper (IP) to $57 from $66 as he sees the two bearing the burden of maintaining market balance as he expects high containerboard prices to encourage a growing number of capacity additions. Connelly, who now projects about 3% capacity growth annually for the industry through 2022, believes Packaging Corp. (PKG) should trade at a significant premium as he sees it having multiple internal conversion prospects. He maintains Equal Weight ratings on WestRock and International Paper and an Overweight rating on Packaging Corp.
07/23/18
SBSH
07/23/18
INITIATION
Target $65
SBSH
Buy
International Paper resumed with a Buy at Citi
Citi analyst Anthony Pettinari resumed coverage of International Paper with a Buy rating and $65 price target. The rating is unchanged while the target is lowered from $71 relative to Citi's prior coverage. The last time International Paper traded at this steep of a discount to the S&P 500 Index, the stock outperformed the market by 2,800 basis points over the near- to mid-term, Pettinari tells investors in a research note. He expects a "more disciplined capital allocation approach" that favors buybacks and debt paydown over acquisitions following the company's decision to not to issue a third bid for SKG.
HSY Hershey
$92.85

0.79 (0.86%)

07/06/18
RBCM
07/06/18
NO CHANGE
Target $99
RBCM
Sector Perform
Hershey price target lowered to $99 from $103 at RBC Capital
RBC Capital analyst David Palmer lowered his price target on Hershey to $99 and kept his Sector Perform rating, citing a 3% decline in the "lackluster baseline sales trends over the past four weeks" as well as the 2% decline in those sales year-to-date. Palmer adds that he is especially concerned with the 1% year-to-date decline in Reese's franchise sales, which represented about 25% of the company's U.S. candy/gum segment growth since 2014. The analyst does note that Hershey may soon recover on easier manufacturing constraints as well as the launch of Reese's Outrageous candy in Q3.
06/13/18
FBCO
06/13/18
DOWNGRADE
FBCO
Underperform
Hershey downgraded to Underperform from Neutral at Credit Suisse
06/13/18
06/13/18
DOWNGRADE
Target $80

Underperform
Hershey downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Moskow downgraded Hershey to Underperform from Neutral and lowered his price target on the shares to $80 from $90. The analyst believes that the shift in shopping patterns to more convenient methods like online and click-and-collect will materially reduce the number of impulse purchase occasions for confectionery products merchandised at traditional checkout aisles. Moskow expects Hershey's operating margin to head lower over the next two years as it increases its investment spending to contend with this challenge and struggles to raise prices to offset higher cocoa input costs.
07/09/18
CEDG
07/09/18
DOWNGRADE
CEDG
Equal Weight
Hershey downgraded to Equal Weight from Overweight at Consumer Edge
AAL American Airlines
$38.15

0.76 (2.03%)

07/03/18
07/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL), American Airlines (AAL), and Delta Airlines (DAL) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying in a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market. 2. Belmond (BEL) downgraded to Underweight from Overweight at Barclays with analyst Felicia Hendrix citing an analysis of the company's progress on its growth targets announced back in June 2016. 3. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank with analyst Jonathan Arnold saying The Federal Energy Regulatory Commission order raised new questions over New Jersey zero-emission credits. 4. PepsiCo (PEP) downgraded to Hold from Buy at Deutsche Bank with analyst Stephen Powers viewing the current valuation as a "bit bubbly." 5. Watsco (WSO), Fastenal (FAST), and Grainger (GWW) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he thinks the cycle and individual company results could remain solid for quarters or years to come, but he believes the cycle is in its later stages, thereby elevating risks to gross margins, rising labor costs, and earnings deceleration in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/18
IMPC
07/12/18
NO CHANGE
Target $50
IMPC
Outperform
American Airlines price target lowered to $50 from $56 at Imperial Capital
Imperial Capital analyst Michael Derchin lowered his price target for American Airlines Group to $50 to reflect high fuel prices and reduced Q2 unit revenues. The analyst, however, believes American will reduce capacity starting in the post-labor day off-peak period, likely resulting in improved pricing power and higher valuations. He keeps an Outperform rating on the shares.
07/12/18
BUCK
07/12/18
NO CHANGE
Target $63
BUCK
Buy
American Airlines selloff overdone, says Buckingham
Buckingham analyst Daniel McKenzie believes American Airlines (AAL) selloff is overdone and reiterates a Buy rating and a $63 price target on the stock. The analyst is attributing slight yield weakness in Q2 to United Continental (UAL) growth across American Airlines markets which decelerates sequentially into Q3, and also, LATAM demand trends that are beginning to pause. Nonetheless, McKenzie believes LATAM does not derail the overall revenue narrative which is poised to improve for the remainder of the year, aided by commercial initiatives, solid domestic demand, and a supply backdrop that improves in key markets.
07/16/18
LEHM
07/16/18
NO CHANGE
Target $68
LEHM
Equal Weight
Barclays lowers Airlines targets to reflect 'more realistic' valuations
Barclays analyst Brandon Oglenski reduced his price targets across the North America Airlines group to reflect near-term earnings headwinds from higher fuel prices as well as a "more realistic valuation outlook." Nonetheless, domestic U.S. demand "appears quite strong," with 2018 industry revenue expected to expand high single digits, Oglenski tells investors in a research note. He believes discussion of incremental capacity reductions through earrings season could help put a floor in stock prices. The analyst lowered his price target for Underweight-rated Allegiant Travel Company (ALGT) to $117 from $135, for Equal Weight-rated Alaska Air Group (ALK) to $68 from $80, for Overweight-rated American Airlines Group (AAL) to $60 from $68, for Overweight-rated Delta Air Lines (DAL) to $62 from $73, for Overweight-rated JetBlue Airways (JBLU) to $27 from $29, for Equal Weight-rated Southwest Airlines (LUV) to $65 from $74, for Equal Weight-rated Spirit Airlines (SAVE) to $42 from $49 and for Overweight-rated United Continental Holdings (UAL) to $78 from $80.
LLL L3 Technologies
$200.33

-0.14 (-0.07%)

05/22/18
FBCO
05/22/18
NO CHANGE
Target $218
FBCO
Outperform
L3 Technologies price target lowered to $218 from $244 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for L3 Technologies to $218 from $244 as he downgrades his outlook for Defense hardware stocks to neutral from bullish. The analyst reiterates an Outperform rating on the shares.
03/29/18
03/29/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA), Allegheny Technologies (ATI), Textron (TXT), Spirit AeroSystems (SPR), Northrop Grumman (NOC), Bombardier (BDRBF), Huntington Ingalls (HII), L3 (LLL) and General Dynamics (GD) were initiated with an Overweight at Barclays, while Arconic (ARNC), Harris (HRS), Lockheed Martin (LMT), Triumph Group (TGI), Raytheon (RTN) and Hexcel (HXL) initiated with an Equal Weight and Esterline (ESL) and BWX Technologies (BWXT) were initiated wtih an Underweight. 2. Spotify (SPOT) initiated with an Outperform at RBC Capital. 3. International Paper (IP) initiated with a Buy at UBS. 4. American Homes 4 Rent (AMH) and Invitation Homes (INVH) initiated with an Outperform at Baird. 5. Pilgrim's Pride (PPC) initiated with a Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/18
LEHM
03/29/18
INITIATION
Target $274
LEHM
Overweight
L3 Technologies initiated with an Overweight at Barclays
Barclays analyst David Strauss started L3 Technologies (LLL) with an Overweight rating and $274 price target. The analyst believes expectations for U.S. Aerospace & Defense are too low and initiated the sector with a Positive rating. Fundamentals look poised to deliver accelerating growth against consensus, the analyst contends. He favors TransDigm Group (TDG) in Aerospace and his top pick overall is L3 Technologies.
07/11/18
JEFF
07/11/18
NO CHANGE
Target $220
JEFF
Hold
L3 Technologies shares pricing in restructuring benefits, says Jefferies
Jefferies analyst Sheila Kahyaoglu believes L3 Technologies is emerging from a multi-year portfolio reshaping that should bolster its sales growth and margin outlook. The analyst expects L3's sales grow at 5% annually through 2020 and its EBIT margins to expand by 200 basis points. However, the stock's valuation suggests that the improvement is largely baked into expectations, without factoring in execution risk, Kahyaoglu tells investors in a research note. She raised her price target for L3 to $220 from $218 and keeps a Hold rating on the name.
DHI D.R. Horton
$39.54

-0.83 (-2.06%)

06/27/18
RBCM
06/27/18
INITIATION
RBCM
Sector Perform
D.R. Horton assumed with a Sector Perform at RBC Capital
06/19/18
SBSH
06/19/18
INITIATION
Target $46
SBSH
Neutral
D.R. Horton assumed with a Neutral at Citi
Citi analyst Scott Schrier assumed coverage of D.R. Horton with a Neutral rating and $46 price target. The analyst took over coverage of the Building Products, Construction Materials group.
03/26/18
03/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intel (INTC) and Analog Devices (ADI) upgraded to Outperform from Market Perform at Raymond James. 2. D.R. Horton (DHI) upgraded to Overweight from Equal Weight at Barclays with analyst Matthew Bouley saying he sees the company as well positioned to absorb volume demand while maintaining gross margins. 3. RBS (RBS) upgraded to Buy from Hold at Deutsche Bank with the firm saying the recent underperformance of shares has brought an attractive entry point. 4. MetLife (MET) upgraded to Overweight from Neutral at Atlantic Equities. 5. Dollar Tree (DLTR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Peter Keith saying he believes the company is making "sensible investments" with Family Dollar to drive comp growth improvement into 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/18
RBCM
06/27/18
INITIATION
Target $45
RBCM
Sector Perform
D.R. Horton assumed with a Sector Perform at RBC Capital
RBC Capital analyst Michael Dahl assumed D.R. Horton with a Sector Perform rating and a price target of $45. The analyst notes that the company is "strongly positioned to capitalize on the lack of affordable existing home inventory and capture entry-level demand, while also generating strong free cash flows" but also sees those factors reflected in its valuation, as it trades at a premium to peer group average on total book value and PE multiple basis.
LEA Lear
$181.53

2.175 (1.21%)

06/25/18
BARD
06/25/18
NO CHANGE
Target $235
BARD
Outperform
Lear price target raised to $235 from $227 at Baird
Baird analyst David Leiker raised his price target on Lear to $235 from $227 ahead of the company's analyst day. He believes the meeting could provide the background to drive the valuation higher in 2019. He said its competitive positioning has never been stronger, which he said could bias valuation even higher over time. Leiker reiterated his Outperform rating on Lear shares.
05/14/18
05/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Neutral at BofA/Merrill with analyst Ken Hoexter saying he thinks UPS's Network Transformation plan that will be launched in a couple months will improve its cost structure and margins, and could prove to be the turning point for the company and drive the multiple back toward historical levels. 2. FMC Corporation (FMC) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the solid first quarter report convinced him to change his rating as pro forma orgnaic growth rates were very strong, and earnings contribution from the DowDuPont (DWDP) acquisition far exceeded his expectations. 3. L Brands (LB) upgraded to Buy from Neutral at Citi with analyst Paul Lejuez saying he acknowledges this is "not an 'all's clear' type of call," and that things may get worse before they get better, however, he feels consensus sentiment has become so bearish and the stock's valuation is "just too cheap to ignore." 4. Lear (LEA) upgraded to Outperform from In Line at Evercore ISI with analyst Chris McNally saying he sees double digit earnings growth through 2020 with earnings growth set to accelerate in 2019 on the back of the GM truck launch and acceleration of E-Systems given megatrends in Electrification & Connectivity. 5. CSX (CSX) upgraded to Neutral from Sell at Goldman Sachs with analyst Matt Reustle citing better risk/reward following successful execution of Q1 network initiatives. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/14/18
05/14/18
UPGRADE
Target $220

Outperform
Lear upgraded to Outperform, growth set to accelerate, says Evercore ISI
As previously reported, Evercore ISI upgraded Lear to Outperform from In Line and raised its price target to $220 from $180. Analyst Chris McNally sees double digit earnings growth through 2020 with earnings growth set to accelerate in 2019 on the back of the GM truck launch and acceleration of E-Systems given megatrends in Electrification & Connectivity.
06/28/18
BARD
06/28/18
NO CHANGE
Target $235
BARD
Outperform
Lear investor day showcases opportunity, says Baird
Baird analyst David Leiker said Lear's investors day showcased a compelling opportunity highlighted by its broad portfolio of technology, which strongly positions the company across both seating and e-systems as vehicles become more connected, autonomous, and electrified. Leiker reiterated his Outperform rating and $235 price target on Lear shares.
ALLY Ally Financial
$27.97

0.1 (0.36%)

06/19/18
NOMU
06/19/18
INITIATION
Target $28
NOMU
Neutral
Ally Financial initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Bill Carcache initiated coverage of Ally Financial with a Neutral rating and $28 price target. Ally's generates the lowest returns in financials, and its inability to cover its cost of capital has led shares to trade between 0.5-1.0 times tangible book value since the initial public offering in 2014, Carcache tells investors in a research note. The analyst sees the stock being range-bound by tangible book value and notes that "weak" industry fundamentals add to his cautiousness. Carcache cites valuation for his Neutral rating.
06/19/18
06/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ollie's Bargain Outlet (OLLI) initiated with a Hold at Loop Capital. 2. B&G Foods (BGS) assumed with a Neutral at Piper Jaffray. 3. Iterum Therapeutics (ITRM) initiated with an Outperform at RBC Capital and Leerink while being initiated with a Buy at Needham and Guggenheim. 4. Ingersoll-Rand (IR) initiated with an Outperform at Cowen. 5. Ally Financial (ALLY) initiated with a Neutral at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/29/18
JANY
06/29/18
UPGRADE
JANY
Buy
Ally Financial upgraded to Buy from Neutral at Janney Montgomery Scott
06/29/18
06/29/18
UPGRADE

Buy
Janney upgrades Ally Financial, Santander Consumer to Buy on CCAR results
As previously reported, Janney Montgomery Scott analyst John Rowan upgraded both Santander Consumer (SC) and Ally Financial (ALLY), each to Buy from Neutral, after the Federal Reserve released the results of its Comprehensive Capital Analysis and Review, or CCAR, tests and did not object to the capital plans for either. The capital actions approved for Santander Consumer do not alleviate its excess capital, but they are "significant," Rowan tells investor. Meanwhile, Ally's share repurchase plan is 32% higher than last year, noted Rowan, who raised his EPS estimates for both companies. He has a $36 fair value estimate on Ally shares and a $24 fair value estimate for Santander Consumer.
IVZ Invesco
$26.36

0.125 (0.48%)

07/13/18
KBWI
07/13/18
DOWNGRADE
KBWI
Market Perform
Invesco downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee downgraded Invesco to Neutral and cut his price target to $29 from $36 telling investors he expects flow trends to remain challenging over the near term and sees few near-term catalysts for improvement despite a discounted valuation.
02/01/18
FBCO
02/01/18
UPGRADE
Target $42
FBCO
Outperform
Invesco upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Craig Siegenthaler last night upgraded Invesco to Outperform while lowering his price target for the shares to $42 from $43. The operating expense reset with yesterday's Q4 results, recent sell-side downgrades, and share price underperformance over the last six months presents an upgrade opportunity and attractive valuation, Siegenthaler tells investors in a research note.
02/01/18
02/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. eBay (EBAY) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney citing the "ongoing acceleration in Marketplace gross merchandise volume, the surprise announcement that eBay will intermediate payments, and materially ramped up share repurchases." 2. Textron (TXT) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Rajeev Lalwani citing the growing chances he sees of a bizjet recovery, the stock's relative underperformance over the last year and upside levers that include R&D cuts, M&A, or more capital returns. 3. Invesco (IVZ) upgraded to Outperform from Neutral at Credit Suisse with analyst Craig Siegenthaler saying the operating expense reset with yesterday's fourth quarter results, recent sell-side downgrades, and share price underperformance over the last six months presents an upgrade opportunity and attractive valuation. 4. Baker Hughes (BHGE) upgraded to Neutral from Sell at Goldman Sachs with analyst Waqar Syed saying he believes expectations have been reset lower over the last six months and highlights his firm's more favorable commodity price outlook. 5. AMD (AMD) upgraded to Buy from Hold at Argus with analyst Jim Kelleher saying the latest quarterly results demonstrate the "sustainability of the company's return to consistent profitability and top and bottom-line growth." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/18
DBAB
02/13/18
UPGRADE
Target $38
DBAB
Buy
Invesco upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Brian Bedell upgraded Invesco to Buy while lowering his price target for the shares to $38 from $39. The analyst views the recent pullback in shares as a buying opportunity. Asset manager valuations are now "significantly depressed" relative to better fundamentals, Bedell tells investors in a research note.
NLSN Nielsen
$29.56

0.05 (0.17%)

07/02/18
GSCO
07/02/18
DOWNGRADE
Target $28
GSCO
Sell
Nielsen downgraded to Sell with $28 price target at Goldman Sachs
Goldman Sachs analyst George Tong downgraded Nielsen Holdings to Sell from Neutral and cut his price target for the shares to $28 from $35. Sustained operating headwinds in developed Consumer Packaged Goods markets will keep the company's Buy segment revenue growth under pressure over the near-to-intermediate term, Tong tells investors in a research note. Further, the analyst expects Nielsen's investment activities to weigh on its EBITDA margin performance over the next two-to-four quarters. As such, Tong sees risk of downward revisions to earnings and free cash flow estimates.
07/02/18
GSCO
07/02/18
DOWNGRADE
Target $28
GSCO
Sell
Nielsen downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst George Tong downgraded Nielsen Holdings to Sell and lowered his price target for the shares to $28 from $35. The analyst views the Buy segment as challenging and sees headwinds to the company's margins.
06/04/18
06/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Prudential (PRU) upgraded to Buy from Neutral at Goldman Sachs with analyst Alex Scott citing the company's "strong" cash flow and capital deployment yield for his upgrade. 2. Dollar General (DG) upgraded to Buy from Accumulate at Gordon Haskett. 3. AB InBev (BUD) upgraded to Buy from Hold at HSBC and Ambev (ABEV) upgraded to Hold from Reduce at HSBC. 4. Discovery (DISCA) and Nielsen (NLSN) were upgraded to Buy from Hold at Pivotal Research. 5. CSS Industries (CSS) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser saying he sees improving organic sales trends and an attractive free cash flow yield. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/04/18
PIVT
06/04/18
UPGRADE
Target $35
PIVT
Buy
Nielsen upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Brian Wieser upgraded Nielsen to Buy from Hold, stating that he thinks investor sentiment has become too negative though its fundamentals are not really worse than they were earlier in the year. Wieser. who thinks the long-term durability of the business remains in place, maintains a $35 price target on Nielsen shares.
TSCO Tractor Supply
$78.15

-0.2 (-0.26%)

07/17/18
DBAB
07/17/18
NO CHANGE
Target $75
DBAB
Buy
Tractor Supply price target raised to $75 from $65 at Deutsche Bank
Deutsche Bank analyst Mike Baker raised his price target for Tractor Supply to $75 saying favorable inflation trends should lead to strong comps. The analyst upped his his Q2 comp estimate to 4.0% from 3.0%. He keeps a Hold rating on the shares, however, citing some concerns longer term.
07/12/18
RBCM
07/12/18
NO CHANGE
Target $75
RBCM
Sector Perform
Tractor Supply price target raised to $75 from $67 at RBC Capital
RBC Capital analyst Scot Ciccarelli raised his price target on Tractor Supply to $75, saying that after a slow Q2 start in April due to winter weather conditions, the sales velocity has likely "snapped back" in May/June to capture the pent-up demand for spring products. The analyst keeps his Sector Perform rating however, citing " concerns over continuing margin pressure and longer-term e-commerce competition."
07/16/18
BARD
07/16/18
NO CHANGE
Target $90
BARD
Outperform
Tractor Supply price target raised to $90 from $85 at Baird
Baird analyst Peter Benedict raised his price target on Tractor Supply to $90 from $85 as his favorable seasonal checks and proprietary survey work caused him to raise estimates ahead of next week's earnings report. The analyst noted a healthy demand backdrop and recommends investors stay involved in the name as he sees the potential for margin stabilization. Benedict reiterated his Outperform rating on Tractor Supply shares.
07/18/18
WEDB
07/18/18
NO CHANGE
Target $77
WEDB
Neutral
Tractor Supply price target raised to $77 from $65 at Wedbush
Wedbush analyst Seth Basham raised his price target for Tractor Supply to $77 from $65 ahead of quarterly results as he expects "good" a quarter fueled by weather. Nonetheless, the analyst reiterates a Neutral rating on the shares given high investor expectations for a beat and raise and his view that much of the strength is being driven by favorable weather that may not persist.
BWA BorgWarner
$44.02

-0.41 (-0.92%)

07/18/18
07/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Outperform from In Line at Evercore ISI with analyst John Pancari saying he expects earnings growth to outpace peers while returns continue to strengthen, supported by a favorable positioning for higher short-term rates, ongoing efficiency improvement, and intact credit. 2. BorgWarner (BWA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Richard Kwas saying he sees limited share price downside risk and disproportionate upside potential from the current share price. 3. Avon Products (AVP) upgraded to Hold from Underperform at Jefferies with analyst Stephanie Wissink saying she believes shares of Avon are close to fair value. 4. Sunoco (SUN) upgraded to Hold from Underperform at Jefferies with analyst Christopher Sighinolfi saying while he still expects a 30% distribution cut and "equity needs" resulting from elevated leverage, he no longer sees "sufficient downside" with the shares down 10% since early April. 5. CSX (CSX) upgraded to Buy from Hold at Loop Capital with analyst Rick Paterson saying CSX is making "continued progress on the adoption of its scheduled operating model," delivering an operating ratio of 59.8% in Q2 vs. 64.7% last year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link
07/18/18
WELS
07/18/18
UPGRADE
Target $56
WELS
Outperform
BorgWarner upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Richard Kwas upgraded BorgWarner to Outperform while lowering his price target for the shares to $56 from $57.
07/18/18
WELS
07/18/18
UPGRADE
Target $56
WELS
Outperform
BorgWarner upgraded to Outperform on upside potential at Wells Fargo
As previously reported, Wells Fargo analyst Richard Kwas upgraded BorgWarner to Outperform from Market Perform as he sees limited share price downside risk and disproportionate upside potential from the current share price. The company will host an investor day in mid-September, which he thinks could be a positive catalyst. Specifically, the analyst believes BorgWarner will increase its estimates for hybrid and electric content per vehicle and outline more robust growth potential from vehicle electrification. Kwas also trimmed his price target on the shares to $56 from $57.
07/23/18
OPCO
07/23/18
NO CHANGE
Target $58
OPCO
Outperform
BorgWarner price target lowered to $58 from $63 at Oppenheimer
Oppenheimer analyst Colin Rusch lowered his price target for BorgWarner to $58 from $63 on a lower valuation multiple. The analyst reiterates an Outperform rating on the shares.
UAA Under Armour
$21.09

0.48 (2.33%)

07/18/18
SBSH
07/18/18
NO CHANGE
Target $22
SBSH
Neutral
Under Armour turnaround similar to Ralph Lauren's, says Citi
Citi analyst Kate McShane believes Under Armour (UAA) and Ralph Lauren (RL) "have a lot in common." Both are founder-led companies with iconic brands in the midst of a turnaround, McShane tells investors in a research note. Further, the analyst notes that both companies are significantly reducing product size, modifying distribution and focusing on international opportunities. McShane believes that Ralph Lauren has an 18-24 month head start on its turnaround strategy, however. The analyst raised her price target for Under Armour to $22 from $18 and keeps a Neutral rating on the shares.
07/19/18
JEFF
07/19/18
NO CHANGE
JEFF
Buy
Jefferies says Under Armour discounts down four straight months, buy shares
Jefferies analyst Randal Konik says July webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is down for the fourth month in a row, while Adidas's (ADDYY) is up five months in a row. The analyst's visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR and Curry 5 sneakers are sold out in many sizes/colors, indicating "strong sell-through." Further, Nike (NKE) continues to regain share from Adidas in running across the U.S., with strength in Air VaporMax and Air Max 270, Konik tells investors in a research note titled "SNEAKER WARS: UAA HOVRing Above The Rest. Buy This Stock." He believes the data are encouraging and reinforce his belief in the upside potential for Under Armour shares.
07/20/18
WEDB
07/20/18
NO CHANGE
Target $18
WEDB
Neutral
Under Armour price target raised to $18 from $15 at Wedbush
Wedbush analyst Christopher Svezia raised his price target on Under Armour to $18 from $15 ahead of the company's earnings report on July 26 but maintained a Neutral rating, citing the lack of visibility around a global growth strategy and margin recapture ramp. In a research note to investors, Svezia says that he sees a pathway towards financial improvement and believes the company's FY18 outlook seems "achievable," but contends that brand direction is a "major" stumbling block. Svezia says he, like other investors, has "more questions than answers" and awaits a prospective analyst meeting later this year.
07/24/18
DBAB
07/24/18
NO CHANGE
Target $16
DBAB
Hold
Deutsche has negative bias on Under Armour with shares up 44%
Deutsche Bank analyst Paul Trussell says he has a negative bias on Under Armour with the stock up 44% year-to-date. He maintains a Hold rating on the shares with a $16 price target. The most pressing concerns into the Q2 results are inventory levels and the company's ability to maintain gross profit margin guidance for the full year, Trussell tells investors in a pre-earnings research note. The analyst views Under Armour's valuation as expensive at current share levels.
UA Under Armour
$19.73

0.49 (2.55%)

ALK Alaska Air
$59.12

0.15 (0.25%)

05/03/18
STFL
05/03/18
NO CHANGE
STFL
Stifel says Alaska, JetBlue may be targets if 'Big 4' think they can consolidate
Stifel analyst Joseph DeNardi said in a note to investors prior to the open that the proposed merger of Sprint (S) and T-Mobile (TMUS), and the related approval process, is the first major test of the Trump administration's view on consolidation. Depending on how this case plays out, management teams at the "Big 4" airlines would have significant interest in acquiring Alaska Air (ALK) or JetBlue (JBLU) if they think they could be successful in doing so, he contends. He believes the current consensus in the industry is that Alaska will serve as buyer and consolidator within its segment, but should the Big 4 believe that they could be permitted to be buyers, the M&A outlook would likely change, DeNardi tells investors.
06/01/18
IMPC
06/01/18
NO CHANGE
Target $65
IMPC
In-Line
Alaska Air price target lowered to $65 from $71 at Imperial Capital
Imperial Capital analyst Michael Derchin lowered his price target for Alaska Air Group to $65 saying competition in California will likely result in earnings pressure through fiscal 2019. The analyst reduced his estimates for the company and keeps an In-Line rating on the shares.
07/03/18
DBAB
07/03/18
NO CHANGE
DBAB
Deutsche downgrades three airlines on 'headline risk' from trade dispute
Deutsche Bank analyst Michael Linenberg downgraded his ratings on American Airlines Group (AAL), Delta Air Lines (DAL) and United Continental (UAL) to Hold from Buy. The analyst cut his price target for American to $43 from $60, for Delta to $53 from $64 and for United to $74 from $81. In a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market, Linenberg tells investors in a research note. The possibility that the current trade dispute between the U.S. and its global partners could become something bigger is problematic for the airline industry's sales growth, the analyst adds. Further, Linenberg argues, the growing trade dispute may cause U.S. companies to reconsider their spending and employment plans, which would adversely impact corporate travel. As a result, the analyst sees "headline risk" and a lack of near-term catalysts for the airline stocks. He keeps Buy ratings on Alaska Air (ALK), Allegiant Travel (ALGT), JetBlue Airways (JBLU), Southwest Airlines (LUV), Spirit Airlines (SAVE) and SkyWest (SKYW).
HP Helmerich & Payne
$58.78

-0.4 (-0.68%)

06/19/18
06/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Buy from Hold at Deutsche Bank with analyst Matthew Niknam saying the company's fundamentals are inflecting but the shares have remained range-bound. 2. Intuit (INTU) upgraded to Buy from Hold at Stifel with analyst Brad Reback saying he believes its two primary business divisions each have improving competitive dynamics and multiple secular growth drivers. 3. First Solar (FSLR) upgraded to Neutral from Underperform at Credit Suisse with analyst Michael Weinstein saying the recent pull back captures potential downside risk from U.S. tariff withdrawal. 4. Helmerich & Payne (HP) upgraded to Buy from Hold at Jefferies with analyst Brad Handler saying the stock's 13% pullback over the past month is unwarranted. 5. Accenture (ACN) upgraded to Positive from Neutral at Susquehanna with analyst James Friedman saying he is incrementally more bullish that an ERP modernization cycle is starting. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/18
JEFF
06/19/18
UPGRADE
Target $80
JEFF
Buy
Helmerich & Payne upgraded to Buy from Hold at Jefferies
Jefferies analyst Brad Handler upgraded Helmerich & Payne to Buy and raised his price target for the shares to $80 from $72. The stock's 13% pullback over the past month is unwarranted, Handler tells investors in a research note. The analyst expects any Permian fall-off to "be shallow and limited" to the second half of 2018. Further, he believes U.S. land drilling fundamentals remain strong. Helmerich retains "best-in-class exposure to a super-spec rig market" that should allow for strong free cash flow inflection through the next 24 months, the analyst contends.
04/27/18
FBCO
04/27/18
NO CHANGE
Target $63
FBCO
Underperform
Helmerich & Payne price target raised to $63 from $51 at Credit Suisse
Credit Suisse analyst James Wicklund raised his price target on Helmerich & Payne to $63 from $51, telling investors in a research note that it is among the "highest quality" companies operating in the land rig space, but it "can't support the valuation." Wicklund, who has an Underperform rating on shares, said H&P is set to take more than its fair share of the high-spec rigs market, which remains tight.
04/27/18
SUSQ
04/27/18
NO CHANGE
Target $84
SUSQ
Positive
Helmerich & Payne price target raised to $84 from $75 at Susquehanna
Susquehanna analyst Charles Minervino raised his price target on Helmerich & Payne to $84 from $75 which reflects an improved outlook for its U.S. rigs, coupled with slightly higher utilization forecasts for its international fleet. Minervino reiterated his Positive rating on Helmerich & Payne shares.
XRX Xerox
$24.77

-0.02 (-0.08%)

07/20/18
SBSH
07/20/18
INITIATION
Target $39
SBSH
Buy
Xerox resumed with a Buy at Citi
Citi analyst Jim Suva resumed coverage of Xerox with a Buy rating and $39 price target.
05/16/18
LOOP
05/16/18
NO CHANGE
Target $40
LOOP
Buy
Xerox price target lowered to $40 from $45 at Loop Capital
Loop Capital analyst Ananda Baruah lowered his price target on Xerox (XRX) to $40, citing the potential operating disruptions from the company's leadership "saga" and the firm position by Fujifilm (FUJIY) not to raise its bid price. The analyst says his new price is based on the stand-alone value of the company with no added potential deal related benefits. Baruah also keeps his Buy rating on Xerox, adding that there is a greater "appreciation" by the recently appointed CEO John Visentin to pass on more cost savings toward profitability.
05/14/18
05/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dean Foods (DF) downgraded to Sell from Hold at Deutsche Bank analyst Rob Dickerson saying he still sees four fundamental challenges facing the company: continued declines in U.S. dairy milk consumption, its low-margin structured business, increasing vertical category integration by retailers, and what he views as low odds of transformative acquisitions. 2. Owens Corning (OC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Stephen East saying his outlook for Roofing and Composites has weakened and extremely weak year to date 2018 hail/storm activity is likely an incremental headwind to 2H18 Shingle Volumes while inflationary cost pressures are more intense than originally expected. 3. Xerox (XRX) downgraded to Neutral from Overweight at JPMorgan and to Hold from Buy at Cross Research. 4. Jeld-Wen (JELD) downgraded to Neutral from Buy at BofA/Merrill with analyst John Lovallo saying he believes the company will face challenges from the CEO search, Steves & Sons litigation, wood windows, and believes a margin recovery could take longer than expected. 5. Hostess Brands (TWNK) downgraded to Hold from Buy at Deutsche Bank with analyst Rob Dickerson saying he is less certain on the base business' potential margin and profitability progression over the next twelve months following the company's recent earnings report. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/18
STPT
07/10/18
UPGRADE
STPT
Buy
Xerox upgraded to Buy from Hold at Standpoint Research
DNKN Dunkin' Brands
$70.92

-0.23 (-0.32%)

07/09/18
07/09/18
UPGRADE

Neutral
Dunkin' Brands upgraded to Neutral following in-line checks at Longbow
As previously reported, Longbow analyst Alton Stump upgraded Dunkin' Brands (DNKN) to Neutral from Underperform after his conversations with U.S. franchisees lead him to believe the company's Q2 same-store sales rose 0.5-1.0%, which would be in-line with the consensus view and slightly better than his prior forecast for them to have been flat with last year. However, he added that the "still tepid" same-store sales growth likely means the coffee company lost share, especially to McDonald's (MCD), in the U.S. during Q2.
07/20/18
MAXM
07/20/18
NO CHANGE
MAXM
Dine Brands, Dave & Buster's added to Maxim's Top Picks in Restaurants
Maxim analyst Stephen Anderson updated his preferred stock picks in the Restaurant group for the second half of 2018. The analyst is keeping Del Taco (TACO) as the top pick, modeling a potential 32% upside to his $19 price target. He also adds Dine Brands (DIN) based on its recent sales momentum and Dave & Busters (PLAY) based on its VR offerings driving traffic. Anderson removes Darden Brands (DRI) and Dunkin' Brands (DNKN) from his top picks selection as those stocks have recently seen their prices reach his targets.
07/09/18
07/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. FireEye (FEYE) upgraded to Overweight from Neutral at Piper Jaffray with analyst Andrew Nowinski saying a recent round of channel checks showed a "significant improvement" in demand trends for the company. 2. BP (BP) upgraded to Top Pick from Outperform at RBC Capital with analyst Biraj Borkhataria saying the company's visibility for volume growth will lead to higher cash flows from operations. 3. Capital One (COF) upgraded to Outperform from Perform at Oppenheimer with analyst Ben Chittenden saying the delinquency formation is improving and Q2 expectations seem too low to him. 4. Dunkin' Brands (DNKN) upgraded to Neutral from Underperform at Longbow with analyst Alton Stump saying his conversations with U.S. franchisees lead him to believe the company's Q2 same-store sales rose 0.5-1.0%, which would be in-line with the consensus view and slightly better than his prior forecast for them to have been flat with last year. 5. Baidu (BIDU) upgraded to Outperform from Neutral at Credit Suisse and to Overweight from Sector Weight at KeyBanc. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
LBOW
07/09/18
UPGRADE
LBOW
Neutral
Dunkin' Brands upgraded to Neutral from Underperform at Longbow
WWE WWE
$81.27

0.29 (0.36%)

07/24/18
NEED
07/24/18
NO CHANGE
Target $100
NEED
Buy
WWE price target raised to $100 from $80 at Needham
Needham analyst Laura Martin raised her price target on WWE to $100 and kept her Buy rating, citing the valuation upside coming from "subscriber revenue and linear TV fee growth outside the U.S." The analyst notes that the viewing trend shifts toward the internet "over-the-top" format on connected TVs and smartphones is benefiting the company, as its premium video content targets those devices. Martin adds that with "millions of wrestling fans creating short form content and sharing it with their friends globally", WWE can drive incremental ad revenue from those posts without any additional content costs.
07/19/18
MKMP
07/19/18
NO CHANGE
Target $95
MKMP
Buy
WWE Q2 has upside potential, says MKM Partners
MKM Partners analyst Eric Handler kept his Buy rating and $95 price target on WWE ahead of its Q2 earnings, saying that despite the great year for its stock price, there is further upside potential. Handler notes that the outperformance "would likely be driven by contributions from proceeds associated with The Greatest Royal Rumble, which was held in Saudi Arabia on April 27th". The analyst also states that the premium on WWE is "merited given the unique nature of this independent, content play and the high level of earnings visibility over the next 5-6 years."
07/13/18
MSCO
07/13/18
NO CHANGE
Target $100
MSCO
Overweight
WWE price target raised to $100 from $58 at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne said that WWE (WWE), by securing rights fees in its new five-year agreements with NBC (CMCSA) and Fox (FOXA) that are 3.6 times higher than its prior five-year broadcast agreement with NBC, has gained a "massive increase" in earnings power and "extremely high" visibility into the associated revenue. Given the recently announced deals, he raised his estimates for the company's smaller UK and India rights renewals as well as for its domestic 2024/25 renewal period and increased his price target on WWE shares to $100 from $58. Swinburne keeps an Overweight rating on WWE.
SYNT Syntel
$40.69

-0.06 (-0.15%)

06/20/18
WELS
06/20/18
DOWNGRADE
WELS
Underperform
Syntel downgraded to Underperform from Market Perform at Wells Fargo
07/23/18
LOOP
07/23/18
DOWNGRADE
Target $41
LOOP
Hold
Syntel downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Joseph Vafi downgraded Syntel to Hold from Buy and raised his price target to $41 from $36 after the company's $41 per share acquisition by Atos announced this weekend. The analyst contends that given its size, Syntel is unlikely to induce a bidding war while also noting the attractiveness of its margin structure and North American market presence.
06/21/18
06/21/18
DOWNGRADE
Target $29

Underperform
Syntel downgraded to Underperform on valuation at Wells Fargo
As previously reported, Wells Fargo analyst Ed Caso downgraded Syntel to Underperform from Market Perform on valuation after strong move in the shares. The analyst also raised his price target on the stock to $29 from $26.
07/23/18
BRRR
07/23/18
NO CHANGE
BRRR
Market Perform
Barrington sees low possibility of Syntel receiving higher bid
Barrington analyst Vincent Colicchio sees a low possibility of a higher bid emerging for Syntel. The likelihood that another strategic buyer emerges is low due to the favorable valuation of this morning's deal, and the probability that a financial buyer emerges is even lower, Colicchio tells investors in a research note after Syntel signed a definitive agreement with Atos to be acquired for $41 per share in cash. The analyst keeps a Market Perform rating on Syntel.
TPX Tempur Sealy
$49.94

-1.15 (-2.25%)

07/10/18
WEDB
07/10/18
NO CHANGE
Target $65
WEDB
Outperform
Mattress sales 'soft,' Tempur Sealy likely below consensus for Q2, says Wedbush
Following checks with retailers across the U.S., Wedbush analyst Seth Basham told investors in a research note that nationwide brick-and-mortar retail mattress sales declined in the low-single digits in the second quarter, and though sales grew early in the quarter, they declined in May and June. Based on his checks, Basham says 4th of July period sales declined low-single digits to mid-single digits for B&M retailers, driven by steepening traffic declines and ASP gains, and that Tempur Sealy (TPX) specifically is likely to be below consensus for the quarter, with sales trends weakening due to elevated cannibalization rates as customers traded down to new, lower-priced products. He believes Tempur Sealy will maintain at least the low end of of its 2018 EBITDA guidance of $450M-$500M. Additionally, Basham says Sleep Number (SNBR) may be "slightly light" of consensus for the quarter, as his checks show that sales trends remained muted for the 4th of July period. The analyst has an Outperform rating and $65 price target on Tempur Sealy and a Neutral rating and $34 price target on Sleep Number.
05/07/18
RHCO
05/07/18
NO CHANGE
Target $45
RHCO
Hold
Tempur Sealy price target lowered to $45 from $51 at SunTrust
SunTrust analyst Keith Hughes lowered his price target on Tempur Sealy to $45 and kept his Hold rating after the company's Q1 earnings miss, saying that while international sales supported results, the non-mattress accounts continued to weaken. The analyst adds that a "substantial success" will be needed from the product launches this year and in 2019 to recapture historical growth rate levels. Hughes also warns that raw material inflation will likely remain elevated in the current quarter before leading to another price increase later in the year.
04/16/18
LOOP
04/16/18
DOWNGRADE
Target $36
LOOP
Sell
Tempur Sealy downgraded to Sell from Hold at Loop Capital
Loop Capital analyst Laura Champine downgraded Tempur Sealy to Sell and cut her price target for the shares to $36 from $49. The shares closed Friday down 12c to $44.00. Channel checks with vendors, customers, and competitors this quarter "have not gone well" for Tempur, particularly for the Sealy line, Champine tells investors in a research note. The mattress business is "highly promotional," and competitor Mattress Firm "is taking this to a new level in its stores," the analyst adds. She believes that despite investor hopes, Tempur Sealy seems "highly unlikely" to return to Mattress Firm stores. The analyst feels it "no longer makes sense" to ignore the competitive pressure Tempur is facing.
04/12/18
KEYB
04/12/18
NO CHANGE
KEYB
KeyBanc uncovers another retailer moving away from Tempur Sealy
KeyBanc analyst Bradley Thomas came across an "interesting datapoint that is negative" for Tempur Sealy (TPX) during his recent mattress industry channel checks. A smaller retailer, with less than 50 stores, is in the process of changing its floor to Serta Simmons Bedding from Tempur, Thomas tells investors in a research note. Despite being pleased with Tempur's product and productivity, the retailer said Serta-Simmons was offering substantially better terms, Thomas writes. He believes this development, which follows Conn's (CONN) similar decision in Q4, highlights the "continued competitive challenges" in the mattress sector. Thomas has a Sector Weight rating on Tempur Sealy. The stock in afternoon trading is down 35c to $44.19.

TODAY'S FREE FLY STORIES

TRQ

Turquoise Hill

$1.07

-0.02 (-1.83%)

18:32
07/15/19
07/15
18:32
07/15/19
18:32
Hot Stocks
Turquoise Hill reports Q2 copper output 39.2KT, down 0.6% from last year »

Reports Q2 Gold output…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$61.50

0.77 (1.27%)

18:29
07/15/19
07/15
18:29
07/15/19
18:29
Hot Stocks
Rio Tinto cuts FY19 Pilbara ore shipments view to 320M-330M tons »

Prior view was 333M-343M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RIO

Rio Tinto

$61.50

0.77 (1.27%)

18:28
07/15/19
07/15
18:28
07/15/19
18:28
Hot Stocks
Rio Tinto report Q2 Pilbara iron ore output 79.7M tons, down 7% from last year »

Reports Q2 Pilbara iron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

VMW

VMware

$172.22

2.48 (1.46%)

18:24
07/15/19
07/15
18:24
07/15/19
18:24
Hot Stocks
VMware: We have momentum across the board »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

CGIX

Cancer Genetics

$0.17

-0.0059 (-3.35%)

, IDXG

Interpace Diagnostics

$0.70

-0.0071 (-1.01%)

18:21
07/15/19
07/15
18:21
07/15/19
18:21
Conference/Events
Interpace Diagnostics to hold a conference call »

Conference call to…

CGIX

Cancer Genetics

$0.17

-0.0059 (-3.35%)

IDXG

Interpace Diagnostics

$0.70

-0.0071 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:55
07/15/19
07/15
17:55
07/15/19
17:55
Conference/Events
Stephens business services analyst to hold a group dinner »

Group Dinner Meeting to…

EYEN

Eyenovia

$2.89

0.04 (1.40%)

17:51
07/15/19
07/15
17:51
07/15/19
17:51
Hot Stocks
Eyenovia CEO buys 233.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ET

Energy Transfer LP

$14.91

0.09 (0.61%)

17:38
07/15/19
07/15
17:38
07/15/19
17:38
Periodicals
Energy Transfer considering sale of 33% Rover pipeline stake, Bloomberg says »

Energy Transfer (ET) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNT

Innovate Biopharmaceuticals

$1.12

0.02 (1.82%)

17:37
07/15/19
07/15
17:37
07/15/19
17:37
Hot Stocks
Innovate Biopharmaceuticals gives corporate update, undertakes CEO search effort »

Innovate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAMR

Lamar Advertising

$80.70

-0.31 (-0.38%)

17:36
07/15/19
07/15
17:36
07/15/19
17:36
Hot Stocks
Lamar Advertising to acquire Ashby Street Outdoor Holdings »

Ashby Street Outdoor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

LMT

Lockheed Martin

$367.65

-1.81 (-0.49%)

17:24
07/15/19
07/15
17:24
07/15/19
17:24
Hot Stocks
Lockheed Martin awarded $492.11M Army contract for M142 launchers »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

EGHT

8x8, Inc.

$25.62

-0.24 (-0.93%)

, FIVN

Five9

$48.00

-5.53 (-10.33%)

17:15
07/15/19
07/15
17:15
07/15/19
17:15
Conference/Events
Stephens communications analysts to hold an analyst/industry conference call »

Communications Analysts,…

EGHT

8x8, Inc.

$25.62

-0.24 (-0.93%)

FIVN

Five9

$48.00

-5.53 (-10.33%)

LOGM

LogMeln

$76.57

0.41 (0.54%)

RNG

RingCentral

$123.31

0.34 (0.28%)

WORK

Slack Technologies

$34.78

1.04 (3.08%)

TWLO

Twilio

$145.36

3.185 (2.24%)

VG

Vonage

$12.79

-0.2 (-1.54%)

ZM

Zoom Video

$99.76

6.465 (6.93%)

GOOG

Alphabet

$1,150.39

5.84 (0.51%)

MSFT

Microsoft

$138.94

0.08 (0.06%)

AMZN

Amazon.com

$2,021.00

10.38 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

WTI

W&T Offshore

$4.83

0.13 (2.77%)

17:08
07/15/19
07/15
17:08
07/15/19
17:08
Hot Stocks
W&T Offshore CEO buys 100K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRT

StarTek

$7.10

0.04 (0.57%)

17:08
07/15/19
07/15
17:08
07/15/19
17:08
Syndicate
Breaking Syndicate news story on StarTek »

StarTek files $100M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

VTVT

vTv Therapeutics

$1.37

(0.00%)

17:08
07/15/19
07/15
17:08
07/15/19
17:08
Hot Stocks
vTv Therapeutics jumps 20% after saying it will make presentation at AAIC »

vTv Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBHT

J.B. Hunt

$92.50

-0.45 (-0.48%)

16:53
07/15/19
07/15
16:53
07/15/19
16:53
Hot Stocks
Breaking Hot Stocks news story on J.B. Hunt »

J.B. Hunt up over 6% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 26

    Aug

  • 13

    Nov

ARW

Arrow Electronics

$68.82

-0.15 (-0.22%)

16:52
07/15/19
07/15
16:52
07/15/19
16:52
Hot Stocks
Breaking Hot Stocks news story on Arrow Electronics »

Arrow Electronics down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBNK

United Financial

$14.02

-0.1 (-0.71%)

16:45
07/15/19
07/15
16:45
07/15/19
16:45
Hot Stocks
Breaking Hot Stocks news story on United Financial »

United Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

TRWH

Twin River Worldwide

$28.90

-0.08 (-0.28%)

16:44
07/15/19
07/15
16:44
07/15/19
16:44
Hot Stocks
Standard General to tender 13M shares from Twin River Worldwide »

Twin River Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQY

HealthEquity

$70.29

-1.38 (-1.93%)

16:44
07/15/19
07/15
16:44
07/15/19
16:44
Hot Stocks
HealthEquity director Robert Selander buys 610K in company shares »

HealthEquity director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSS

TSYS

$133.45

1.26 (0.95%)

, GPN

Global Payments

$165.94

1.69 (1.03%)

16:39
07/15/19
07/15
16:39
07/15/19
16:39
Hot Stocks
Global Payments establishes new credit agreement to support merger with TSYS »

Global Payment (GPN)…

TSS

TSYS

$133.45

1.26 (0.95%)

GPN

Global Payments

$165.94

1.69 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 13

    Nov

ECOR

electroCore

$1.61

0.01 (0.63%)

16:34
07/15/19
07/15
16:34
07/15/19
16:34
Syndicate
electroCore files registration statement on Form S-3 »

electroCore announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFMS

Conformis

$3.40

-0.265 (-7.23%)

16:31
07/15/19
07/15
16:31
07/15/19
16:31
Hot Stocks
Conformis announces alliance with Regent Surgical Health »

Conformis announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

VIAB

Viacom

$31.72

0.02 (0.06%)

, VIA

Viacom

$36.15

-0.15 (-0.41%)

16:30
07/15/19
07/15
16:30
07/15/19
16:30
Periodicals
CBS and Viacom set August deadline for merger talks, CNBC reports »

According to CNBC's…

VIAB

Viacom

$31.72

0.02 (0.06%)

VIA

Viacom

$36.15

-0.15 (-0.41%)

CBS

CBS

$53.37

0.18 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

16:30
07/15/19
07/15
16:30
07/15/19
16:30
Options
Preliminary option volume of 15.2M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.